Skip to main content
Smart Investors Daily
NO

NASDAQ · NOVTU

Novanta Inc. Tangible Equity Units

Technology · Hardware, Equipment & Parts

$69.08

Down-$0.75 (-1.07%)

Updated Aug 17, 2026, 7:32 AM

SID Score

6.3/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
2B
P/E ratio
81.9
Dividend yield
3.39%
52-week range
$50.70 – $75.59
Volume
1.52K
Avg. volume
492.9K

Price performance

NOVTU price history

1M range · 20 trading sessions · Daily adjusted prices

NOVTU closed at $69.08 after 20 trading sessions, up 12.05% for the selected period.

Last close
$69.08
Period change
+12.05%
Period low
$60.00
Period high
$69.96
Daily close
View OHLC price history
NOVTU OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 14, 2026$69.20$69.20$69.07$69.081.52K
Aug 13, 2026$75.00$75.00$67.52$69.833.24K
Aug 12, 2026$69.00$69.96$69.00$69.961.59K
Aug 11, 2026$75.26$75.26$68.55$68.959.98K
Aug 10, 2026$67.92$68.58$67.68$68.426.3K
Aug 7, 2026$75.59$75.59$69.11$69.1138.76K
Aug 6, 2026$69.55$72.29$67.90$67.9059.39K
Aug 5, 2026$65.51$65.76$64.40$64.404.06K
Aug 4, 2026$64.75$66.82$64.75$66.8259.14K
Aug 3, 2026$62.43$62.88$62.02$62.8516.15K
Jul 31, 2026$60.83$61.83$60.69$60.9824.6K
Jul 30, 2026$59.49$60.475$59.49$60.0027.7K
Jul 29, 2026$60.18$61.01$59.36$60.045148.99K
Jul 28, 2026$59.74$61.32$59.59$60.276.27K
Jul 27, 2026$60.71$60.90$60.215$60.863.16K
Jul 24, 2026$60.76$61.35$60.45$60.786.35K
Jul 23, 2026$61.58$61.87$61.02$61.2610.4K
Jul 22, 2026$63.78$63.91$62.03$62.076.66K
Jul 21, 2026$63.33$63.68$62.47$62.471.34K
Jul 20, 2026$62.31$62.70$61.60$61.652.03K

Latest NOVTU news

The latest Smart Investors Daily articles mentioning NOVTU.

NOVTU research

Overview

Company profile and research snapshot.

Company profile

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
Implied upside
Analysts
10
NOVTU recent ratings
DateFirmRatingTarget
May 13, 2026BairdOutperform
Mar 30, 2026BairdOutperform
Aug 11, 2025BairdNeutral
Mar 3, 2025BairdNeutral
Nov 6, 2024BairdNeutral
Open full forecast

News briefing

No generated briefing is available yet.

SeekingAlpha · Jun 10, 2026

Novanta Inc. (NOVT) M&A Call Transcript

Novanta Inc. (NOVT) M&A Call June 9, 2026 8:30 AM EDTCompany ParticipantsRay Nash - Corporate Finance Leader & IRMatthijs Glastra - CEO &...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.